Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolated from Southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole

Japanese Journal of Infectious Diseases

Volumn 57, Issue 3, 2004, Pages 113-115

  Chang, Wen Neng ^a   Huang, Chi Ren ^a   Lei, Chien Bang ^a   Lee, Ping Yu ^a   Chien, Chun Chih ^a   Chang, Hsueh Wen ^b   Chang, Chen Sheng ^c   Lu, Cheng Hsien ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; FLUCONAZOLE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CEREBROSPINAL FLUID CULTURE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIUM; FUNGUS ISOLATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SEROTYPE; TAIWAN;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CEREBROSPINAL FLUID; COLONY COUNT, MICROBIAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; SEROTYPING; TAIWAN; TRIAZOLES;

EID: 4143137747     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Saag, M. S., Graybill, R. J., Larsen, R. A., Pappas, P. G., Perfect, J. R., Powderly, W. G., Sobel, J. D. and Dismukes, W. E. (2000): Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin. Infect. Dis., 30, 710-718.
2. Espinel-Ingroff, A. (1998): In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J. Clin. Microbiol., 36, 198-202.
3. Kwon-Chung, K. J., Polachek, I. and Bennett, J. E. (1982): Improving diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotype A and D) and Cryptococcus neoformans var. gattii (serotype B and C). J. Clin. Microbiol., 15, 535-537.
4. Salkin, I. E. and Hurd, N. J. (1982): New medium for differentiation of Cryptococcus neoformans serotype pairs. J. Clin. Microbiol., 15, 169-171.
5. Shadomy, H. J., Wood-Helie, S., Shadomy, S., Dismukes, W. E., Chau, R. Y. and the NIAID Mycoses Study Group (1987): Biochemical serogrouping of clinical isolates of Cryptococcus neoformans. Diagn. Microbiol. Infect. Dis., 6, 131-138.
6. Ikeda, R., Shinoda, T., Fukazawa, Y. and Kaufman, L. (1982): Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J. Clin. Microbiol., 16, 22-29.
7. Hsu, M. L., Chang, J. C., Yokoyama, K., Nishimura, K. and Miyaji, M. (1994): Serotypes and mating types of clinical strains of Cryptococcus neoformans isolated in Taiwan. Mycopathologia, 125, 77-81.
8. Perfect, J. R. and Casadevall, A. (2002): Cryptococcosis. Infect. Dis. Clin. N. Am., 16, 837-874.
9. Mondon, P., Petter, R., Amalfitano, G., Luzzati, R., Concia, E., Polacheck, I. and Kwon-Chung, K. J. (1999): Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans. Antimicrob. Agents Chemother., 43, 1856-1861.
10. López-Jodra, O., Torres-Rodriguez, J. M., Méndez-Vásquez, R., Ribas-Forcadell, E. and Morera-López, Y. (2000): In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method. J. Antimicrob. Chemother., 45, 645-649.
11. Lozano-Chiu, M., Paetznick, V. L., Ghannoum, M. A. and Rex, J. H. (1998): Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performance of three different media assessed by using E-Test and National Committee for Clinical Laboratory Standards M27-A methodologies. J. Clin. Microbiol., 36, 2817-2822.
12. Speed, B. and Dunt, D. (1995): Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin. Infect. Dis., 21, 28-34.
13. Chen, Y. C., Chang, S. C., Shih, C. C., Hung, C. C., Luh, K. T., Pan, Y. S. and Hsieh, W. C. (2000): Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan. Diag. Microbiol. Infect. Dis., 36, 175-183.